drugset / Trial / NCT04768829

Antifungal Potential of Moringa Olifera Against Otomycosis

NCT04768829

Phase 0 Completed 10 enrolled Deraya University Minia University · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

patients with Otomycosis were recognized by an ENT specialist. 20 patients were distributed randomly into two groups. The first group will be treated with Nystatin ear drops twice daily. The second group will be treated with Moringa ear drops. patients will be examined endoscopically by the ENT specialist. patient's swabs will be isolated and analyzed by ELISA.

Timeline

Start
2021-02-18
Primary completion
2021-09-15
Completion
2021-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Moringa oleifera leaf Unknown 10 mg Other

Indications